← capex_spike (all companies) · ARWR (all signals) · all methodology

capex_spike on ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

SIC 2834 — Pharmaceutical Preparations · CIK 879407 · default direction: short

Definition

Fires on >50% YoY capex increase. Captures aggressive reinvestment phases — often precedes value destruction in mature industries.

Every time the signal fired on ARWR

FYFiling dateEvent date1d5d20d60d252d
FY20242024-11-262024-11-26+24.23%+9.79%-7.22%-8.65%+167.22%
FY20232023-11-292023-11-29-26.85%-17.91%+6.97%+7.54%-10.18%
FY20202020-11-232020-11-23-11.45%-8.15%+21.45%+24.63%+3.94%
FY20162016-12-142016-12-14+0.00%+0.00%+62.20%+63.78%+148.03%
FY20142014-11-252014-11-25-1.03%-8.39%+8.73%+32.36%+4.11%
FY20122012-12-282012-12-28+5.42%+6.40%-1.48%+9.36%+427.09%

Forward returns are stock returns from event date (next trading day after filing). Sign is raw stock direction; the trade direction is in the calibration table below.

Universe-wide calibration (this signal across all companies)

Horizonn eventsGross stock retHit rateTrade dirNet PnLCost (bps)r/σ net
1d2,295+0.01%+43.27%short-0.06%32-0.01
5d2,292-0.85%+41.88%short+0.74%33+0.06
20d2,258-1.91%+41.67%short+2.05%36+0.10
60d2,127+0.65%+44.01%short-0.78%47-0.02
252d2,092+14.03%+44.93%short-14.91%97-0.09

Net PnL is direction × stock return − round-trip execution cost (5 bps half-spread + ADV-tiered borrow). See capex_spike methodology for the full audit.


Data: /api/company/879407/financials